Saturn V Capital Management LP Q4 2024 Filing
Filed February 14, 2025
Portfolio Value
$255.4B
Holdings
24
Report Date
Q4 2024
Filing Type
13F-HR
All Holdings (24 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | IRONDISC MEDICINE INC | 509,406 | $32.3B | 12.65% | |
| 2 | ASNDASCENDIS PHARMA A/S | 198,977 | $27.4B | 10.73% | |
| 3 | MLTXMOONLAKE IMMUNOTHERAPEUTICS | 346,111 | $18.7B | 7.34% | |
| 4 | CGONCG ONCOLOGY INC | 593,262 | $17.0B | 6.66% | |
| 5 | PCVXVAXCYTE INC | 204,285 | $16.7B | 6.55% | |
| 6 | CYTKCYTOKINETICS INC | 348,364 | $16.4B | 6.42% | |
| 7 | CRGXCARGO THERAPEUTICS INC | 1,007,677 | $14.5B | 5.69% | |
| 8 | CELCCELCUITY INC | 1,063,783 | $13.9B | 5.45% | |
| 9 | SNDXSYNDAX PHARMACEUTICALS INC | 988,528 | $13.1B | 5.12% | |
| 10 | XENEXENON PHARMACEUTICALS INC | 322,470 | $12.6B | 4.95% | |
| 11 | ARGXARGENX SE | 19,754 | $12.1B | 4.76% | |
| 12 | COGTCOGENT BIOSCIENCES INC | 1,498,425 | $11.7B | 4.58% | |
| 13 | MRUSMERUS N V | 234,637 | $9.9B | 3.86% | |
| 14 | CTNMCONTINEUM THERAPEUTICS INC | 573,022 | $8.4B | 3.29% | |
| 15 | ABVXABIVAX SA | 653,071 | $4.8B | 1.87% | |
| 16 | KALVKALVISTA PHARMACEUTICALS INC | 556,489 | $4.7B | 1.85% | |
| 17 | INZYINOZYME PHARMA INC | 1,374,582 | $3.8B | 1.49% | |
| 18 | IRWDIRONWOOD PHARMACEUTICALS INC | 814,533 | $3.6B | 1.41% | |
| 19 | AMLXAMYLYX PHARMACEUTICALS INC | 889,073 | $3.4B | 1.32% | |
| 20 | CRNXCRINETICS PHARMACEUTICALS IN | 59,125 | $3.0B | 1.18% | |
| 21 | SLNSILENCE THERAPEUTICS PLC | 395,024 | $2.7B | 1.06% | |
| 22 | NAMSNEWAMSTERDAM PHARMA COMPANY | 100,000 | $2.6B | 1.01% | |
| 23 | OCULOCULAR THERAPEUTIX INC | 191,456 | $1.6B | 0.64% | |
| 24 | MBXMBX BIOSCIENCES INC | 18,000 | $331.7M | 0.13% |